Veracyte (VCYT) Invested Capital (2012 - 2026)

Veracyte has disclosed Invested Capital across 15 years of filings, most recently posting $1.4 billion for Q2 2026.

• In Q2 2026, Invested Capital rose 12.52% year-over-year to $1.4 billion; the TTM figure through Jun 2026 stood at $1.4 billion (up 12.52% YoY), while the FY2025 annual figure was $1.3 billion, up 9.89% from the prior year.
• Invested Capital came in at $1.4 billion for Q2 2026 at Veracyte, up from $1.3 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.4 billion in Q2 2026 to a low of $1.0 billion in Q4 2023.
• Average Invested Capital over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2024.
• Year-over-year, Invested Capital retreated 5.0% in 2022 and increased 13.97% in 2024.
• Over 5 years, Invested Capital stood at $1.1 billion in 2022, then slipped by 3.3% to $1.0 billion in 2023, then advanced by 13.97% to $1.2 billion in 2024, then advanced by 9.89% to $1.3 billion in 2025, then advanced by 5.96% to $1.4 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $1.4 billion in Q2 2026, $1.3 billion in Q1 2026, and $1.3 billion in Q4 2025.